ScholarIQanswers from OpenAlex & ORCID
John Wilding
ResearcherPublications, citations & collaboration network
John Wilding is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John Wilding have?
ScholarIQindexed works
John Wilding has 727 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John Wilding have?
ScholarIQcitation count
John Wilding has 57,626 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John Wilding?
ScholarIQh-index
John Wilding has an h-index of 95 in OpenAlex.
What is the i10-index of John Wilding?
ScholarIQi10-index
John Wilding has an i10-index of 354 in OpenAlex.
What is the ORCID of John Wilding?
ScholarIQorcid
The ORCID for John Wilding is on the source record.
What is the OpenAlex record for John Wilding?
ScholarIQopenalex
The OpenAlex for John Wilding is on the source record.
What are the most-cited papers on John Wilding?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna, Melanie J. Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara McGowan, Julio Rosenstock, Marie Thi Dao Tran, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F. Kushner
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka, Frank L. Greenway, Alfredo Halpern, Michel Krempf, David C.W. Lau, Carel W. le Roux, Rafael Violante Ortíz, Christine B. Jensen, John Wilding
A role for glucagon-like peptide-1 in the central regulation of feeding
Mandy D. Turton, Donal O’Shea, I. Gunn, S. A. Beak, C. M. B. Edwards, Karim Meeran, S. J. Choi, Gillian M. Taylor, M Heath, Philip Lambert, John Wilding, David M. Smith, Mohammad A. Ghatei, J. Herbert, S.R. Bloom